ACBM
Acro Biomedical Co., Ltd.
$0.03
+0.00 (+0.00%)
At close · Jul 8
Market Cap
$1.56M
Shares
60,042,000
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
FY2025
Net Income
-$101.15K
-139.1%
FY2025
Gross Margin
21.34%
-0.3pp
FY2022
Operating Margin
-2409.98%
-1767.5pp
FY2022
Diluted EPS
$0.00
FY2025
Operating Cash Flow
-$196.3K
-435%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $0 | $0 | $0 | $0 | $658.5K | $1.2M | $687.96K | $193.54K | $8.01M | $510K | — | |
| — | — | — | $0 | $518K | $938K | $528.56K | $181.44K | $7.18M | $459K | — | |
| — | — | — | $0 | $140.5K | $259.5K | $159.4K | $12.1K | $833.4K | $51K | — | |
| — | — | — | — | 21.34% | 21.67% | 23.17% | 6.25% | 10.4% | 10% | — | |
| — | — | $0 | $4.79M | $10.08M | $5.29M | — | — | — | — | — | |
| $205.36K | $154.02K | $37.96K | $3.52M | $5.93M | $2.67M | $289.87K | $434.85K | $317.85K | $866 | $1055 | |
| $205.36K | $154.02K | $37.96K | $8.8M | $16.01M | $7.95M | $289.87K | $434.85K | $317.85K | $53.25K | $43.43K | |
| -$205.36K | -$154.02K | -$37.96K | -$8.8M | -$15.87M | -$7.69M | -$130.46K | -$422.75K | $515.55K | — | $43.43K | |
| — | — | — | — | -2409.98% | -642.47% | -18.96% | -218.44% | 6.43% | — | — | |
| — | — | — | $3206 | $1706 | $893 | $1067 | — | — | — | — | |
| — | $52.88K | -$4339 | — | — | — | -$5082 | -$1983 | -$3663 | — | — | |
| — | -$101.15K | -$42.3K | -$8.81M | -$15.87M | — | -$135.55K | -$424.73K | $511.89K | -$2248 | — | |
| — | $0 | $0 | $0 | $0 | $0 | -$18.09K | -$53.13K | $92.23K | $0 | — | |
| -$134.62K | -$101.15K | -$42.3K | -$8.81M | -$15.87M | -$7.7M | -$117.45K | -$371.6K | $419.66K | -$2248 | -$43.43K | |
| — | — | — | — | -2410.24% | -642.82% | -17.07% | -192.01% | 5.24% | -0.44% | — | |
| USD/shares | — | — | — | — | — | -$0.14 | $0.00 | — | — | — | — |
| USD/shares | — | $0.00 | $0.00 | -$0.15 | -$0.26 | — | — | — | — | — | — |
| shares | — | — | — | — | — | — | 47.76M | 47.76M | 47.66M | 47.17M | 15.72M |
| shares | — | 60.04M | 60.04M | 60.04M | 60.04M | 53.84M | 47.76M | 47.76M | 47.66M | 47.17M | 15.72M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.